← Back to headlines
Vertex to Acquire Crinetics in $10 Billion Deal
Vertex Pharmaceuticals has announced its intention to acquire Crinetics Pharmaceuticals in a deal valued at $10 billion, marking a significant expansion into endocrine disease drugs.
7 Jul, 09:39 — 7 Jul, 09:39
Sources
Showing 1 of 1 sources
